Clinical trial

An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy

NCT02676401

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention MT-3995 Low Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention MT-3995 Middle Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention MT-3995 High Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-02-01

PhasePHASE2

Conditions

Diabetic Nephropathyverified · MONDO: diabetic kidney disease

Interventions

MT-3995 LowDRUG

MT-3995 MiddleDRUG

MT-3995 HighDRUG

Sponsors & collaborators

Tanabe Pharma Corporationlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02676401 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.